Home » Topics » Regulatory

Regulatory
RSS

Diovan approved in Sweden to treat high-risk heart attack patients

Dec. 3, 2004

Atacand approved in Europe for treatment of chronic heart failure

Nov. 30, 2004

Combunox approved for short-term management of acute moderate/severe pain

Nov. 30, 2004

Tysabri approved for multiple sclerosis

Nov. 25, 2004

Tarceva approved for advanced NSCLC

Nov. 22, 2004

Norditropin approved for adults with severe growth hormone deficiency

Nov. 9, 2004

New approval for Eloxatin

Nov. 9, 2004

New indication for Sandostatin injection approved in Japan

Oct. 29, 2004

European approval for Emselex

Oct. 28, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.